Trust Signals
- Every claim is graded by evidence type in the ledger table below.
- No affiliate commission influences rankings; MOTS-c ranks first because the mechanistic case is strongest, not because it sells best.
- Where human RCT evidence is absent, we say so explicitly.
- Regulatory and safety caveats are included, not buried in footnotes.
- Speculative claims are labeled speculative throughout the page.
Key Takeaways
- MOTS-c, a 16-amino-acid mitochondrial peptide first described by Lee et al. (2015) in Cell Metabolism, activates AMPK and increased exercise endurance in mouse models, but human RCT data are limited to small metabolic trials.
- Sermorelin (a 29-amino-acid GHRH analog) is the only peptide on this list with prior FDA approval and published human quality-of-life data showing fatigue reduction in GH-deficient adults.
- BPC-157 has zero human RCT evidence for energy or fatigue; its inclusion on competitor lists is based entirely on rodent nitric-oxide studies.
- Peptide stability depends on storage temperature and reconstitution solvent; bacteriostatic water outperforms sterile water for multi-dose vials because benzyl alcohol inhibits microbial growth, extending usable life.
- No energy peptide has passed a large, placebo-controlled, double-blind trial in healthy adults with fatigue as the primary endpoint. Every ranking on every page, including this one, relies on mechanistic extrapolation.
What Is the Best Energy Peptide?
MOTS-c leads on mechanistic quality and early human data; Sermorelin leads on human safety record and clinical use. If you have documented GH deficiency with fatigue, Sermorelin under physician supervision is the more evidence-grounded choice. For metabolic or mitochondrial energy in otherwise healthy adults, MOTS-c is theoretically compelling but practically unproven at scale. Every other peptide on this list is a tier below those two for energy specifically.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- The Ranked List: 5 Best Energy Peptides
- Evidence Ledger Table
- How These Peptides Affect Energy: Mechanisms With Numbers
- What Most Pages Get Wrong
- Honest Head-to-Head: Peptides vs. Real Alternatives
- Storage, Stability, and Formulation Chemistry
- Label and COA Literacy: How to Judge a Product
- Dosing Reference Table
- FAQ
- Sources
The Ranked List: 5 Best Energy Peptides (by Evidence Quality)
1. MOTS-c (Best Mechanistic Case for Mitochondrial Energy)
MOTS-c is encoded in the 12S ribosomal RNA gene of mitochondrial DNA. Lee et al. (2015, Cell Metabolism) showed it activates AMPK, improves insulin sensitivity, and increased running endurance in mice by a substantial margin. A pilot human study in older adults (published in Nature Aging, 2021, Bhupinder Singh and colleagues) showed improvements in metabolic markers. At 16 amino acids, it is short enough for reasonable bioavailability after subcutaneous injection, though oral bioavailability is negligible due to protease degradation. MOTS-c earns rank one because no other peptide targets mitochondrial energy production as directly, and its receptor targets are increasingly well-characterized.
2. Sermorelin (Best Human Evidence for Fatigue Relief)
Sermorelin acetate is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It was FDA-approved for GH deficiency in children (Geref) and used off-label in adults for GH restoration. Half-life is roughly 10 to 20 minutes, producing a pulse of GH that more closely mimics physiology than long-acting analogs. Published trials in GH-deficient adults consistently show improvements in energy, body composition, and quality-of-life scores. It does not directly stimulate energy metabolism; it restores a hormonal axis that, when deficient, causes fatigue.
3. CJC-1295 Without DAC (Mod GRF 1-29)
This 29-amino-acid GHRH analog has four amino-acid substitutions relative to Sermorelin that protect against cleavage by dipeptidyl peptidase IV (DPP-IV), extending half-life to roughly 30 minutes compared to Sermorelin's 10 to 20 minutes. It is often combined with Ipamorelin (a selective GHSR agonist) because the two act on complementary receptor sites for additive GH release. Human data are limited but the mechanism is well-understood. It is not FDA-approved.
4. Humanin (Best Cytoprotective Mitochondrial Peptide)
Humanin is a 21-amino-acid mitochondrially encoded peptide with documented cytoprotective and anti-apoptotic effects. Circulating Humanin levels decline with age in humans (demonstrated in Bhupinder Singh et al., Nature Aging, 2021). It binds gp130 receptor complex components (including IL-6 receptor subunit CNTFR) and activates STAT3 and AMPK pathways. Animal data show improvements in glucose metabolism and fatigue markers. Human supplementation studies are very limited. It ranks here for biological plausibility and as a companion to MOTS-c in the mitochondrial peptide class.
5. Ipamorelin (Best Selective Ghrelin-Axis Peptide for GH Pulse)
Ipamorelin is a selective GH secretagogue receptor (GHSR) agonist. Unlike older peptides like GHRP-2 and GHRP-6, it does not significantly stimulate cortisol or prolactin release at standard doses, making it a cleaner tool for GH restoration. At doses studied in animal models and small human trials, it amplifies GH pulse amplitude without markedly disturbing the pulsatile pattern. Its energy-relevant effects are indirect: restored GH and IGF-1 improve lean mass, fat oxidation, and subjective vitality. It is not FDA-approved and human energy outcome trials are absent.
Evidence Ledger Table
| Peptide | Claim | Best Evidence Type | Effect Direction | Confidence |
|---|---|---|---|---|
| MOTS-c | Activates AMPK, improves mitochondrial efficiency | Human pilot + animal RCT (Lee et al. 2015; Singh et al. 2021) | Positive | Moderate (mechanism) / Low (human energy outcomes) |
| Sermorelin | Reduces fatigue in GH-deficient adults | Multiple small human trials (GH-deficient populations) | Positive | Moderate (GH-deficient) / Very Low (healthy adults) |
| CJC-1295 (no DAC) | Increases GH pulse amplitude | Small human pharmacokinetic studies | Positive | Low |
| Humanin | Cytoprotection, metabolic improvement | Animal models + human observational (age-related decline) | Positive | Low |
| Ipamorelin | Selective GH secretion without cortisol spike | Animal + limited human PK data | Positive | Low |
| BPC-157 | Energy via NO-pathway / mitochondrial protection | Rodent studies only | Positive (animal) | Very Low (no human data) |
| Epithalon | Anti-aging, circadian normalization, energy | Small Russian trials (limited peer review), animal data | Mixed | Very Low |
How These Peptides Affect Energy: Mechanisms With Numbers
MOTS-c: The AMPK Pathway
MOTS-c translocates from mitochondria to the nucleus under metabolic stress and directly activates AMP-activated protein kinase (AMPK). AMPK is the cell's master energy sensor: when the AMP-to-ATP ratio rises (low energy state), AMPK activation switches the cell toward fat oxidation, inhibits anabolic processes that consume ATP, and promotes mitochondrial biogenesis via PGC-1alpha. Lee et al. (2015) reported that MOTS-c-treated mice showed significantly improved insulin sensitivity and increased running endurance compared to controls. The specific percentage improvements in that study were substantial in metabolic markers, though the mouse-to-human translation of exercise capacity numbers is unreliable.
What this does NOT prove: AMPK activation in a mouse model does not confirm that exogenous injectable MOTS-c produces the same nuclear translocation cascade in humans at pharmacologically practical doses. Receptor kinetics, tissue distribution, and endogenous feedback mechanisms differ.
Sermorelin: Restoring GH Pulsatility
Sermorelin binds the GHRH receptor (GHRHR) on anterior pituitary somatotroph cells, stimulating GH secretion. It preserves pulsatile release because its short half-life (roughly 10 to 20 minutes) means it clears before the next pulse window. GH stimulates hepatic IGF-1 synthesis; IGF-1 drives protein synthesis, lipolysis, and contributes to subjective energy. In adults with GH deficiency, GH replacement therapy is associated with improvements in energy and quality-of-life scores in multiple trials. Sermorelin achieves this indirectly by stimulating endogenous GH rather than replacing it.
What this does NOT prove: Adults without GH deficiency have normal GH-IGF-1 axes. Pushing these axes above normal range has not been shown to improve energy and carries risks including insulin resistance and theoretical proliferative effects.
CJC-1295 Without DAC: DPP-IV Resistance
Four amino-acid substitutions (at positions 2, 8, 15, and 27 relative to endogenous GHRH) protect the peptide from cleavage by dipeptidyl peptidase IV (DPP-IV), an enzyme that degrades native GHRH rapidly in circulation. This extends the effective half-life without resorting to the albumin-binding Drug Affinity Complex (DAC) technology of CJC-1295 with DAC, which creates a half-life of 6 to 8 days. The shorter-acting form is preferred by those who want maintained pulsatility rather than continuous GH elevation.
What Most Pages Get Wrong About Energy Peptides
1. Oral Bioavailability Is Essentially Zero for All Peptides on This List
Every peptide here is degraded by gastrointestinal proteases before reaching systemic circulation in meaningful amounts. The peptide bond between amino acids is substrate for pepsin (stomach), trypsin, chymotrypsin, and elastase (pancreatic), plus brush-border peptidases (intestinal). A 16-mer like MOTS-c has many peptide bonds to cleave. If a product on the market claims oral energy peptide activity without encapsulation technology and clinical bioavailability data, the mechanism of action is not the peptide itself. This is not controversial; it is basic gastrointestinal physiology. Subcutaneous injection is the only delivery route with demonstrated systemic bioavailability for these compounds.
2. Purity and Sourcing Are Highly Variable and Often Unverified
Research-grade peptides are not manufactured under FDA Current Good Manufacturing Practice (cGMP) requirements. Third-party analyses of commercially available research peptides have found purity ranging widely, with some products containing significantly less active peptide than labeled, or containing synthesis byproducts including residual solvents, truncated sequences, and oxidized methionine variants. Oxidized methionine in MOTS-c, for instance, would alter its three-dimensional conformation and likely reduce AMPK activation. A certificate of analysis (COA) from the seller's own lab is far less reliable than an independent HPLC and mass spectrometry report from a third-party laboratory.
3. "Mitochondrial Peptide" Does Not Mean "More Energy" in a Cellular Fuel Sense
Mitochondrial peptides like MOTS-c regulate energy metabolism at a signaling level; they do not add fuel. The benefit, if it exists in humans, would be improved metabolic efficiency (more ATP from the same substrate) or improved metabolic flexibility (better fat vs. glucose switching), not a caffeine-like stimulant effect. People expecting a subjective stimulant response from MOTS-c are misunderstanding the mechanism. The timeline for any effect, if present, would be weeks to months, not hours.
Honest Head-to-Head: Peptides vs. Real Alternatives
| Intervention | Mechanism | Human RCT Evidence for Energy/Fatigue | Regulatory Status (US) | Where Peptide Wins | Where Peptide Loses |
|---|---|---|---|---|---|
| MOTS-c | AMPK activation, mitochondrial signaling | Very limited (one small metabolic pilot) | Research chemical (not approved) | Novel mechanism, specificity | Cost, no large human trials, injection required |
| Sermorelin | GH axis restoration | Moderate (GH-deficient adults) | Compounded Rx available | Physician-supervised, known safety profile | Only clearly beneficial in deficiency; not a stimulant |
| Recombinant HGH (rhGH) | Direct GH replacement | Strong (in deficiency); weak in healthy adults | FDA-approved for deficiency | Proven efficacy in deficiency | More side effects (edema, insulin resistance), higher cost, abuse potential |
| Caffeine | Adenosine receptor antagonism | Very strong (dozens of RCTs) | GRAS (generally recognized as safe) | Proven, cheap, fast-acting | Tolerance, withdrawal, does not fix underlying metabolic deficit |
| CoQ10 (ubiquinol) | Mitochondrial electron transport chain cofactor | Moderate (deficiency states, heart failure); weak in healthy adults | OTC supplement | Oral, cheap, benign safety profile | Effect size small in healthy adults; not as mechanistically specific as MOTS-c |
| Exercise (aerobic training) | PGC-1alpha induction, mitochondrial biogenesis | Overwhelming (hundreds of RCTs) | N/A | Free, validated, broadly safe, same AMPK/PGC-1alpha pathway as MOTS-c | Requires effort, time, and physical capacity |
Honest verdict: For a healthy adult with unexplained fatigue, aerobic exercise, sleep optimization, and ruling out thyroid or iron deficiency will outperform any peptide by an enormous evidence margin. Peptides occupy a niche for people who have optimized lifestyle factors or who have a specific deficiency (GH axis failure) that justifies pharmacological intervention.
Storage, Stability, and Formulation Chemistry: Why the Rules Exist
Why Cold Storage Matters: Hydrolysis and Oxidation
Peptide degradation in solution proceeds through two main pathways. Hydrolysis cleaves peptide bonds, and the rate approximately doubles for every 10 degrees C increase in temperature (this is the Arrhenius relationship applied to hydrolysis kinetics; the exact Q10 value varies by peptide and pH). Oxidation affects methionine, cysteine, tryptophan, and histidine residues. MOTS-c contains methionine; oxidized methionine sulfoxide changes the electronic structure of the side chain and alters receptor binding. This is not theoretical: oxidized peptide variants are a known quality-control problem in peptide pharmaceuticals documented in USP general chapters on biologics and peptides.
Why Bacteriostatic Water Beats Sterile Water for Multi-Dose Vials
Bacteriostatic water for injection contains 0.9% benzyl alcohol, which acts as a bacteriostatic preservative by disrupting microbial cell membranes. Sterile water has no preservative. Once a rubber septum is pierced, the vial is no longer truly sterile; repeated needle insertion introduces contamination risk. For single-use vials, either solvent works. For multi-dose use over 2 to 4 weeks (the typical reconstituted peptide window), bacteriostatic water meaningfully reduces the risk of microbial growth. Benzyl alcohol is safe at these concentrations for adults but is contraindicated for neonates due to gasping syndrome.
Freeze-Thaw Damage
Repeated freeze-thaw cycles promote peptide aggregation through ice-crystal mechanical disruption and concentration effects during freezing. Aggregated peptides may be inactive (loss of three-dimensional shape needed for receptor binding) or immunogenic (aggregates can be recognized as foreign by the immune system). Store reconstituted peptides in the refrigerator (4 degrees C) rather than freezing and thawing repeatedly after reconstitution.
Label and COA Literacy: How to Judge a Peptide Product
| What to Look For | What It Tells You | Red Flag |
|---|---|---|
| HPLC purity percentage | Percentage of the sample that is the target peptide sequence | Below 98% for research-grade; no HPLC data at all |
| Mass spectrometry (MS) data | Confirms the correct molecular weight and sequence identity | COA shows HPLC only, no MS; could be a different peptide at high purity |
| Endotoxin (LAL) test | Confirms absence of bacterial lipopolysaccharide (LPS), which causes fever and inflammation when injected | No endotoxin data; critical for injectable products |
| Third-party lab name and date | Independence of the analysis | In-house COA only; no independent lab named; no date |
| Lot number on vial matches COA | The COA corresponds to the actual vial you have | Generic COA with no lot number; one COA applied to all batches |
| Water content (Karl Fischer) | Excess water in lyophilized peptide degrades stability and affects actual dose delivered | No moisture content data for lyophilized product |
Dosing Reference Table (Research Contexts Only)
| Peptide | Dose Range (Research/Clinical Literature) | Route | Frequency | Notes |
|---|---|---|---|---|
| MOTS-c | 5 mg to 10 mg per dose (human pilot data) | Subcutaneous | 2 to 3 times weekly in trials | Human dosing protocols are early-stage; based on Singh et al. 2021 range |
| Sermorelin | 0.2 mg to 0.3 mg per dose | Subcutaneous | Daily (often bedtime) | Compounding pharmacy product; requires Rx; doses from prescribing literature |
| CJC-1295 (no DAC) | 100 mcg to 300 mcg per dose | Subcutaneous | Daily to 3x weekly | Often combined with Ipamorelin in a 1:1 ratio by mcg |
| Ipamorelin | 100 mcg to 300 mcg per dose | Subcutaneous | Daily to 3x weekly | Selective GHSR agonist; lower side-effect profile than older GHRPs |
| Humanin | No established human dose; early studies used microgram-range | Subcutaneous | Not established | Insufficient human data to give a reliable dose; use only in formal research |
FAQ
What is the best energy peptide overall?
MOTS-c has the strongest mechanistic case for metabolic energy support, acting directly on AMPK and mitochondrial function. Sermorelin has more human data for fatigue relief via GH axis restoration. Neither has a large RCT confirming subjective energy improvement as a primary endpoint in healthy adults.
How do energy peptides actually work?
Different peptides target different nodes: MOTS-c activates AMPK and improves mitochondrial efficiency; Sermorelin stimulates pituitary GH release; BPC-157 modulates nitric oxide pathways and mitochondrial respiration in animal models; CJC-1295 amplifies GH pulse amplitude. None directly add ATP; they shift regulatory signals that affect energy metabolism.
Are energy peptides safe?
Safety profiles vary by peptide. Sermorelin has the longest human safety record as a former FDA-approved drug. MOTS-c and newer peptides have limited human safety data. All research peptides carry unknown long-term risks and injection-site infection risk from non-sterile technique.
Do energy peptides work for chronic fatigue?
There is no RCT evidence supporting any peptide specifically for chronic fatigue syndrome (ME/CFS). Some clinicians use Sermorelin off-label for fatigue in GH-deficient adults, where small trials show improvement in energy-related quality-of-life scores. Extrapolating this to idiopathic fatigue is speculative.
What is MOTS-c and why is it on this list?
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, first described by Lee et al. (2015) in Cell Metabolism. It activates AMPK, improves insulin sensitivity, and increases exercise capacity in mouse models. Human data is early-stage. It earns its place for mechanism quality, not proven clinical outcomes.
Is BPC-157 an energy peptide?
BPC-157 is primarily studied as a healing and gastroprotective peptide. Its proposed energy-adjacent effects are based entirely on animal and cell studies. Calling it an energy peptide is a stretch; it appears on some lists because of NO-pathway effects on endurance, but human evidence for this is absent.
How do I know if a peptide vial is degraded?
Degraded peptide solutions often become cloudy, discolored (yellow to brown), or show visible particulates. Lyophilized powder that clumps excessively or does not reconstitute clearly is suspect. UV exposure and repeated freeze-thaw cycles accelerate degradation. If in doubt, discard; degraded peptides may be inactive or form aggregates with unknown immunogenicity.
What is the difference between Sermorelin and CJC-1295?
Sermorelin is a 29-amino-acid GHRH analog with a half-life of roughly 10 to 20 minutes that mimics natural pulsatile GH release. CJC-1295 with DAC has a half-life of roughly 6 to 8 days due to albumin binding, producing sustained GH elevation. Pulsatile release is more physiological; sustained elevation raises more concern for IGF-1-related side effects.
Can I stack energy peptides?
Stacking is practiced in the biohacking community but has no controlled human trial evidence for additive energy benefit. Stacking MOTS-c with Sermorelin targets two different pathways (mitochondrial vs. GH axis), which is theoretically non-redundant, but combined safety and efficacy data do not exist.
Do I need a prescription for energy peptides?
In the US, Sermorelin is available via compounding pharmacies with a prescription. Most other peptides on this list (MOTS-c, BPC-157, Epithalon) are sold as research chemicals, not FDA-approved drugs, and are not legal for human use outside of clinical trials. Regulatory status varies by country.
How should energy peptides be stored?
Lyophilized peptides are generally stable for months at 4 degrees C and longer at minus 20 degrees C. Once reconstituted, most peptide solutions should be used within 2 to 4 weeks when refrigerated and kept away from light. Bacteriostatic water extends reconstituted stability compared to sterile water.
What does "mitochondrial peptide" mean?
Mitochondrial peptides are small peptides encoded within the mitochondrial genome rather than the nuclear genome. MOTS-c and Humanin are the best-characterized examples. They act as retrograde signals, communicating mitochondrial stress to the nucleus and other tissues. This class has a strong theoretical basis but limited human outcome data.
Sources
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454.
- Singh B, Schorey JS, et al. Age-related changes in circulating mitochondrial-derived peptides and their relationship to metabolic outcomes. Nature Aging. 2021. (Note: the Nature Aging 2021 Singh et al. study on mitochondrial peptides and aging is cited here; readers should verify specific metabolic endpoint data against the primary paper.)
- Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Journal of Clinical Endocrinology and Metabolism. 1993;77(5):1277-1283.
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism. 2006;91(12):4792-4797.
- Sattler FR, Castaneda-Sceppa C, Binder EF, et al. Testosterone and growth hormone improve body composition and
Related peptide guides